Search Results 381-390 of 21337 for anti-TNF drugs

1. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

   ustekinumab mono or combination therapy;; patients on mesalamine or no therapy. Group B (Low vaccine responders):. Anti-TNF monotherapy;; anti-TNF combination ...

2. Medication Management Clinical Trials - Mayo Clinic Research

   The purpose of this study is to measure patient out-of-pocket outpatient medication cost for patients without prescription drug insurance coverage after ...

3. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

   The purpose of this study is to determine whether plasma exchange as well as immunosuppressive therapy are effective in reducing death and end-stage renal ...

4. Antidepressants: Which cause the fewest sexual side effects? - Mayo Clinic

   Adding a medication to improve sexual function, such as sildenafil (Viagra), tadalafil (Cialis) or vardenafil (Levitra, Staxyn). These medications are approved ...

5. Cancer pain: Relief is possible - Mayo Clinic

   Other prescription medicines. Other types of medicine can help relieve pain, including antidepressants, anti-seizure drugs and steroids. Procedures to block ...

6. Clotrimazole (Mucous Membrane, Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mycelex Troche. Descriptions.

7. Atovaquone And Proguanil (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-tumor necrosis factor (anti-TNF) agents. Patients who have received or ...

9. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Subjects have received anti-TNF treatment within 60 days before baseline (Visit 2).

10. Alefacept (Intramuscular Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Amevive. Descriptions. Alefacept injection is ...